Latest News about JNJ
Recent news which mentions JNJ
The S&P 500 Hasn't Yielded This Little Since the Dot-Com Bubble. Here's What Investors Can Do.
August 24, 2025
From Motley Fool
2 Dividend Stocks Worth Doubling Down on Right Now
August 24, 2025
From Motley Fool
The "Ten Titans" Stocks Now Make Up 38% of the S&P 500. Here's What It Means for Your Investment Portfolio
August 24, 2025
From Motley Fool
From Motley Fool
From AI Hangover To Health Check: Investors Pivot To Defensive Healthcare And U.S. Drug Manufacturing Catalysts
August 22, 2025
From TalkMarkets
From Benzinga
3 Stable Dividend-Paying Stocks That Are Perfect for Retirees
August 21, 2025
From Motley Fool
Congressional Trading Report: Rep. Thomas Kean Sold Over $31K In Johnson & Johnson Stock
August 21, 2025
From Benzinga
Sender Buys Into the Turnaround Story at Kenvue
August 21, 2025
From Motley Fool
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
August 18, 2025
From Benzinga
Massive Headwinds Are on the Horizon for Pharmaceutical Stocks, but Here Are 2 That Could Weather the Storm
August 17, 2025
From Motley Fool
10 Stocks That Give Investors A Little Bit Of Everything
August 16, 2025
From TalkMarkets
These Are the 3 Smartest Dividend Stocks Today
August 16, 2025
From Motley Fool
Palantir Is Now the 19th Largest Public Company. Is This House of Cards About to Come Crashing Down?
August 14, 2025
From Motley Fool
Vor Bio Rallies On Strong Data For Autoimmune Drug Candidate
August 13, 2025
From Benzinga
From Motley Fool
Johnson & Johnson EVP Sells JNJ Shares Worth $3 Million
August 12, 2025
Tickers
JNJ
From Motley Fool
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever
August 12, 2025
From Motley Fool
Novartis' Investigational Drug Aces Two Pivotal Trials For Chronic Disease Impacting Tears, Saliva
August 11, 2025
From Benzinga
5 Dividend Stocks to Hold for the Next 5 Years
August 09, 2025
From Motley Fool
3 Stocks Retirees Should Absolutely Love
August 09, 2025
From Motley Fool
Is the Vanguard Value ETF the Simplest Way to Consistently Collect More Passive Income Than the S&P 500?
August 09, 2025
From Motley Fool
Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%
August 08, 2025
From Benzinga
RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
August 06, 2025
From Benzinga
From Benzinga
3 Medical Stocks To Consider As Markets Take A Breather
August 01, 2025
From TalkMarkets
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.